TY  - JOUR

T1  - Survival benefits of zoledronic acid in patients with bone metastases from non-small cell lung cancer and high NTX levels: The role of BALP.

JO  - J Clin Oncol

PY  - 2008/05/20

AU  - Brown JE

AU  - Hirsh V

AU  - Major PP

AU  - Lipton A

AU  - Cook RJ

AU  - Langer CJ

AU  - Smith MR

AU  - Coleman RE

ED  - 

VL  - 26

IS  - 15_suppl

SP  - 19003

Y2  - 2024/09/19

ER  -